{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:56:49Z","timestamp":1791896209300,"version":"4.3.4"},"reference-count":46,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UZH Foundation","award":["AH"],"award-info":[{"award-number":["AH"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objective: Positron emission tomography\/computed tomography with 18F-fluorodeoxy-glucose (18F-FDG-PET\/CT) has become the standard staging modality in various tumor entities. Cancer patients frequently receive cardio-toxic therapies. However, routine cardiovascular assessment in oncologic patients is not performed in current clinical practice. Accordingly, this study sought to assess whether myocardial 18F-FDG uptake patterns of patients undergoing oncologic PET\/CT can be used for cardiovascular risk stratification. Methods: Myocardial 18F-FDG uptake pattern was assessed in 302 patients undergoing both oncologic whole-body 18F-FDG-PET\/CT and myocardial perfusion imaging by single-photon emission computed tomography (SPECT-MPI) within a six-month period. Primary outcomes were myocardial 18F-FDG uptake pattern, impaired myocardial perfusion, ongoing ischemia, myocardial scar, and left ventricular ejection fraction. Results: Among all patients, 109 (36.1%) displayed no myocardial 18F-FDG uptake, 77 (25.5%) showed diffuse myocardial 18F-FDG uptake, 24 (7.9%) showed focal 18F-FDG uptake, and 92 (30.5%) had a focal on diffuse myocardial 18F-FDG uptake pattern. In contrast to the other uptake patterns, focal myocardial 18F-FDG uptake was predominantly observed in patients with myocardial abnormalities (i.e., abnormal perfusion, impaired LVEF, myocardial ischemia, or scar). Accordingly, a multivariate logistic regression identified focal myocardial 18F-FDG uptake as a strong predictor of abnormal myocardial function\/perfusion (odds ratio (OR) 5.32, 95% confidence interval (CI) 1.73\u201316.34, p = 0.003). Similarly, focal myocardial 18F-FDG uptake was an independent predictor of ongoing ischemia and myocardial scar (OR 4.17, 95% CI 1.53\u201311.4, p = 0.005 and OR 3.78, 95% CI 1.47\u20139.69, p = 0.006, respectively). Conclusions: Focal myocardial 18F-FDG uptake seen on oncologic PET\/CT indicates a significantly increased risk for multiple myocardial abnormalities. Obtaining and taking this information into account will help to stratify patients according to risk and will reduce unnecessary cardiovascular complications in cancer patients.<\/jats:p>","DOI":"10.3390\/jcm9072279","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T03:23:16Z","timestamp":1595388196000},"page":"2279","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Myocardial 18F-FDG Uptake Pattern for Cardiovascular Risk Stratification in Patients Undergoing Oncologic PET\/CT"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5204-4473","authenticated-orcid":false,"given":"Achi","family":"Haider","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bengs","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Schade","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winandus","family":"Wijnen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Portmann","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7060-6089","authenticated-orcid":false,"given":"Dominik","family":"Etter","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Warnock","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Treyer","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fiechter","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"},{"name":"Swiss Paraplegic Center, 6207 Nottwil, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kudura","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-2154","authenticated-orcid":false,"given":"Aju","family":"Pazhenkottil","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Buechel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2422-1281","authenticated-orcid":false,"given":"Alexander","family":"Meisel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Stolzmann","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gebhard","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Center for Molecular Cardiology, University of Zurich, 8952 Schlieren, Switzerland"},{"name":"Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMoa022136","article-title":"Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography","volume":"348","author":"Lardinois","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa0900043","article-title":"Preoperative staging of lung cancer with combined PET-CT","volume":"361","author":"Fischer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.2017.72.2975","article-title":"Prospective Evaluation of Magnetic Resonance Imaging and [(18)F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM\/DFCI 2009 Trial: Results of the IMAJEM Study","volume":"35","author":"Moreau","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1470-2045(07)70244-9","article-title":"PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial","volume":"8","author":"Lordick","year":"2007","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.19.00964","article-title":"Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group","volume":"37","author":"Fuchs","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.jacc.2011.12.040","article-title":"Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: A meta-analysis","volume":"59","author":"Jaarsma","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s00259-019-04344-1","article-title":"Heart rate reserve is a long-term risk predictor in women undergoing myocardial perfusion imaging","volume":"46","author":"Gebhard","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00259-019-4265-7","article-title":"Heart rate reserve during pharmacological stress is a significant negative predictor of impaired coronary flow reserve in women","volume":"46","author":"Haider","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Fiechter, M., Haider, A., Bengs, S., Maredziak, M., Burger, I.A., Roggo, A., Portmann, A., Schade, K., Warnock, G.I., and Treyer, V. (2019). Sex-dependent association between inflammation, neural stress responses, and impaired myocardial function. Eur. J. Nucl. Med. Mol. Imaging.","DOI":"10.1007\/s00259-019-04537-8"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Fiechter, M., Bengs, S., Roggo, A., Haider, A., Maredziak, M., Portmann, A., Treyer, V., Burger, I.A., Messerli, M., and Patriki, D. (2019). Association between vertebral bone mineral density, myocardial perfusion, and long-term cardiovascular outcomes: A sex-specific analysis. J. Nucl. Cardiol.","DOI":"10.1007\/s12350-019-01802-z"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e004316","DOI":"10.1161\/CIRCIMAGING.115.004316","article-title":"Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography\/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome","volume":"9","author":"Rischpler","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12350-015-0258-5","article-title":"Incidental focal myocardial 18F-FDG uptake indicating asymptomatic coronary artery disease","volume":"23","author":"Aikawa","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2967\/jnumed.108.052936","article-title":"Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease","volume":"49","author":"Dou","year":"2008","journal-title":"J. Nucl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1093\/eurheartj\/ehq361","article-title":"Assessment of myocardial ischaemia and viability: Role of positron emission tomography","volume":"31","author":"Ghosh","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2013.55.0459","article-title":"Cardiac effects of anticancer therapy in the elderly","volume":"32","author":"Accordino","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sturgeon, K.M., Deng, L., Bluethmann, S.M., Zhou, S., Trifiletti, D.M., Jiang, C., Kelly, S.P., and Zaorsky, N.G. (2019). A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur. Heart J.","DOI":"10.1093\/eurheartj\/ehz766"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ehjci\/jez047","article-title":"Association between resting amygdalar activity and abnormal cardiac function in women and men: A retrospective cohort study","volume":"20","author":"Fiechter","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/eurheartj\/ehr047","article-title":"Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography","volume":"32","author":"Pazhenkottil","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00259-005-1779-y","article-title":"EANM\/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology","volume":"32","author":"Hesse","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00259-015-3139-x","article-title":"EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT\/CT: 2015 revision","volume":"42","author":"Verberne","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0735-1097(93)90557-H","article-title":"Separate acquisition rest thallium-201\/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: A clinical validation study","volume":"22","author":"Berman","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2019.04.092","article-title":"Quantification of intrathoracic fat adds prognostic value in women undergoing myocardial perfusion imaging","volume":"292","author":"Haider","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_24","first-page":"1420","article-title":"Repeatability of cold pressor test-induced flow increase assessed with H(2)(15)O and PET","volume":"47","author":"Siegrist","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000087432.63671.2E","article-title":"Influence of altitude exposure on coronary flow reserve","volume":"108","author":"Wyss","year":"2003","journal-title":"Circulation"},{"key":"ref_26","first-page":"1626","article-title":"Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: Differential effects in stenotic versus remote myocardial segments","volume":"45","author":"Koepfli","year":"2004","journal-title":"J. Nucl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1055\/s-0039-1692442","article-title":"Sex Differences in the Association between Inflammation and Ischemic Heart Disease","volume":"119","author":"Fiechter","year":"2019","journal-title":"Thromb. Haemost."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Burger, I.A., Lohmann, C., Messerli, M., Bengs, S., Becker, A., Maredziak, M., Treyer, V., Haider, A., Schwyzer, M., and Benz, D.C. (2018). Age- and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imaging. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202302"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2152\/jmi.61.53","article-title":"The physiological uptake pattern of (18)F-FDG in the left ventricular myocardium of patients without heart disease","volume":"61","author":"Nose","year":"2014","journal-title":"J. Med. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7685","DOI":"10.1200\/JCO.2005.08.789","article-title":"Cardiotoxicity of cancer therapy","volume":"23","author":"Floyd","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12149-013-0721-9","article-title":"Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening","volume":"27","author":"Minamimoto","year":"2013","journal-title":"Ann. Nucl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1200\/JCO.2014.58.9465","article-title":"Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer","volume":"33","author":"Niu","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_33","first-page":"4992","article-title":"BNP as a marker for early prediction of anthracycline-induced cardiotoxicity in patients with breast cancer","volume":"18","author":"Lu","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/sj.ki.5000174","article-title":"Cardiac troponins and chronic kidney disease","volume":"69","author":"Kanderian","year":"2006","journal-title":"Kidney Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2014.80","article-title":"PET imaging of inflammation in atherosclerosis","volume":"11","author":"Tarkin","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_36","first-page":"2663","article-title":"Cardiac manifestations of sarcoidosis: Diagnosis and management","volume":"38","author":"Birnie","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/CIRCRESAHA.116.307898","article-title":"Myocardial viability","volume":"120","author":"Gewirtz","year":"2017","journal-title":"Circ. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kim, S.J., Pak, K., and Kim, K. (2019). Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis. J. Nucl. Cardiol.","DOI":"10.1007\/s12350-018-01582-y"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2967\/jnumed.112.105155","article-title":"SNMMI\/ASNC\/SCCT guideline for cardiac SPECT\/CT and PET\/CT 1.0","volume":"54","author":"Dorbala","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_43","first-page":"1059","article-title":"Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials","volume":"47","author":"Shankar","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1148\/rg.315115003","article-title":"How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET\/CT","volume":"31","author":"Maurer","year":"2011","journal-title":"Radiographics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCIMAGING.109.860593","article-title":"Radionuclide imaging of myocardial metabolism","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.74.1.81","article-title":"Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina","volume":"74","author":"Camici","year":"1986","journal-title":"Circulation"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/7\/2279\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:49:27Z","timestamp":1760176167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/7\/2279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["jcm9072279"],"URL":"https:\/\/doi.org\/10.3390\/jcm9072279","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]}}}